Hepatology
From the Journals
Noninvasive ELF test identifies risk of advanced fibrosis in NAFLD
When combined with the fibrosis-4 score, the ELF test may be a reliable method that can assess for advanced fibrosis in clinical practice.
From the Journals
Updated MELD score adds serum albumin, female sex
Despite the utility of the current MELD score, questions have been raised concerning the accuracy of the its ability to predict wait list...
From the Journals
Drink up: Large study confirms coffee beneficial to liver health
“This is the closest we’re ever going to get to a linkage between what people are eating or drinking and the health of their liver.”
From the Journals
Donafenib shows potential as first-line treatment of advanced hepatocellular carcinoma
Donafenib is newly approved in China. It may emerge as a new first-in-line treatment for advanced HCC in China, filling a treatment gap.
From the Journals
AGA Section: Gastroenterology and hepatology training milestones
Milestones 2.0 provide more clarity for programs, faculty, and fellows and could be used to fill gaps.
From the Journals
MRE plus FIB-4 beats FAST for detecting NASH-related fibrosis
Researchers hope to improve prognosis and recruitment to clinical trials.
From the Journals
How do alcohol, obesity impact cirrhosis?
A new analysis suggests that, while alcohol and obesity are risk factors for morbidity, they don’t combine for a stronger effect.
Commentary
COVID-19 and liver disease: Answering the key questions
Data are emerging to help answer some of the major questions - heard both from colleagues and in the clinic - surrounding COVID-19 and the liver...
From the Journals
WTC early responders have higher prevalence of liver disease
The site of the 9/11 attacks exposed responders to hepatotoxic dust, and earliest responders may require special attention and treatment.
From the Journals
Shorter HCC screening intervals benefit high-risk patients
The greatest improvements with shorter screening intervals were seen in patients who had underlying hepatitis B or cirrhosis.
Feature
Call to Action: Multidisciplinary panel urges coordinated care for ‘NASH epidemic’